Richard Giltner - Nov 16, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, under Power of Attorney
Stock symbol
UTHR
Transactions as of
Nov 16, 2022
Transactions value $
-$1,971,500
Form type
4
Date filed
11/17/2022, 03:30 PM
Previous filing
Jul 8, 2022
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $639K +10K +72.1% $63.90 23.9K Nov 16, 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer -$2.61M -10K -41.89% $261.05 13.9K Nov 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -10K -66.67% $0.00 5K Nov 16, 2022 Common Stock 10K $63.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These particular share tracking awards were approaching the end of their 10-year term on June 26, 2023.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.